Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Pyrrolopyrrole aza-BODIPY near-infrared photosensitizer for dual-mode imaging-guided photothermal cancer therapy
Chaolong
Wu
a,
Xiaoyu
Huang
a,
Yunyun
Tang
a,
Wanyue
Xiao
a,
Liguo
Sun
*b,
Jinjun
Shao
*a and
Xiaochen
Dong
*a
aKey Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), Nanjing 211800, China. E-mail: iamxcdong@njtech.edu.cn; iamjjshao@njtech.edu.cn
bDepartment of Radiology, Binzhou Medical University Hospital, Yantai, Shangdong 264100, China. E-mail: zisetasong@sina.com
First published on 3rd July 2023
Abstract
Correction for ‘Pyrrolopyrrole aza-BODIPY near-infrared photosensitizer for dual-mode imaging-guided photothermal cancer therapy’ by Chaolong Wu et al., Chem. Commun., 2019, 55, 790–793, https://doi.org/10.1039/C8CC07768A.
The authors regret that some incorrect images were included in Fig. 3c, on page 792 of the original article. The fluorescence images of the mice at 0 h and 24 h in Fig. 3c of the published work were inadvertently misused during the compilation of Fig. 3c. The mistake was found by the authors after the paper was published online. The results and conclusions of the paper are not affected by this correction. The correct Fig. 3 is presented here, and the figure caption was correct as published.
 | ||
| Fig. 3 (a) In vivo PA images in tumor sites after intravenous injection of PPAB NPs (50 ppm, 100 μL). (b) Photothermal images of tumor-bearing mice exposed to laser irradiation for 8 min after the injection of PBS or PPAB NPs. (c) Fluorescence images of living mice bearing xenograft HeLa tumors at 0, 2, 4, 6, 8, 10, 12 and 24 h post-injection of PPAB NPs. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |